Differential expression of the c-myb proto-oncogene marks the pre-B cell/B cell junction in murine B lymphoid tumors

J Immunol. 1987 Dec 1;139(11):3822-7.

Abstract

A series of murine B lymphoid tumor cell lines which are representative of the pre-B cell, immature and mature B cell, and plasma cell stages of B cell development have been examined for expression of c-myb proto-oncogene mRNA. The pre-B cell lymphoma cell lines express equivalent high steady state levels of c-myb mRNA. In contrast, the B cell lymphoma and plasmacytoma cell lines express steady state c-myb mRNA at levels which are 0.005 to 0.1 times that of the pre-B cell lymphoma lines. These results correlate high levels of c-myb mRNA expression with the pre-B cell stage of development. Subclones of the 1881 pre-B cell lymphoma which express K light chain and are surface IgM-positive as well as two types of hybrid B lymphoid cell lines have been used to demonstrate that surface immunoglobulin expression is not sufficient to result in the down-regulation of c-myb mRNA levels or changes in the expression N-myc mRNA, lambda 5 mRNA, or the BP-1 surface antigen which are markers of the pre-B cell stage of development. Thus, changes in the expression of genes which are independent of immunoglobulin expression are associated with transition from the pre-B cell to the immature B cell stage of development.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Antibodies, Neoplasm / analysis
  • B-Lymphocytes / pathology*
  • Cell Differentiation
  • Gene Expression Regulation*
  • Immunoglobulin M / analysis
  • Lymphoma / pathology*
  • Mice
  • Proto-Oncogene Proteins / biosynthesis*
  • Proto-Oncogene Proteins c-myb
  • RNA, Messenger / analysis
  • Receptors, Antigen, B-Cell / analysis
  • Tumor Cells, Cultured / pathology*

Substances

  • Antibodies, Neoplasm
  • Immunoglobulin M
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-myb
  • RNA, Messenger
  • Receptors, Antigen, B-Cell